DE69323185T2 - Proteinkinase c-inhibitor - Google Patents

Proteinkinase c-inhibitor

Info

Publication number
DE69323185T2
DE69323185T2 DE69323185T DE69323185T DE69323185T2 DE 69323185 T2 DE69323185 T2 DE 69323185T2 DE 69323185 T DE69323185 T DE 69323185T DE 69323185 T DE69323185 T DE 69323185T DE 69323185 T2 DE69323185 T2 DE 69323185T2
Authority
DE
Germany
Prior art keywords
inhibitor
protein kinase
kinase
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69323185T
Other languages
English (en)
Other versions
DE69323185D1 (de
Inventor
Ponnal Nambi
Ashok Dharmaji Patil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69323185D1 publication Critical patent/DE69323185D1/de
Application granted granted Critical
Publication of DE69323185T2 publication Critical patent/DE69323185T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE69323185T 1992-02-24 1993-02-24 Proteinkinase c-inhibitor Expired - Lifetime DE69323185T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84035992A 1992-02-24 1992-02-24
US99294792A 1992-12-17 1992-12-17
PCT/US1993/001619 WO1993016703A1 (en) 1992-02-24 1993-02-24 Protein kinase c inhibitor

Publications (2)

Publication Number Publication Date
DE69323185D1 DE69323185D1 (de) 1999-03-04
DE69323185T2 true DE69323185T2 (de) 1999-07-08

Family

ID=27126180

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69323185T Expired - Lifetime DE69323185T2 (de) 1992-02-24 1993-02-24 Proteinkinase c-inhibitor

Country Status (6)

Country Link
US (1) US5565448A (de)
EP (1) EP0630245B1 (de)
JP (1) JP3375131B2 (de)
AU (1) AU3731293A (de)
DE (1) DE69323185T2 (de)
WO (1) WO1993016703A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
JP3714685B2 (ja) * 1994-05-18 2005-11-09 第一サントリーファーマ株式会社 ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
US5591740A (en) * 1995-06-07 1997-01-07 Osteoarthritis Sciences, Incorporated Use of debromohymenialdisine for treating osteoarthritis
CA2231509C (en) 1995-09-11 2008-07-08 Osteoarthritis Sciences, Inc. Protein tyrosine kinase inhibitors for treating osteoarthritis
US7037891B2 (en) 1997-05-21 2006-05-02 Children's Medical Center Corporation Methods of modulating G-protein-coupled receptor kinase-associated signal transduction
US6833436B2 (en) 1997-05-21 2004-12-21 Children's Medical Center Corporation Short peptides which selectively modulate the activity of serine/threonine kinases
US6174993B1 (en) 1997-05-21 2001-01-16 The Children's Medical Center Corp. Short peptides which selectively modulate the activity of serine/threonine kinases
US6147109A (en) * 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
CA2227688C (en) 1998-01-16 2007-07-31 James W. Critchfield Methods and compositions for inhibition of viral replication
US6103713A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for autoimmune diseases
US6103712A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for asthma
US6180597B1 (en) * 1998-03-19 2001-01-30 Brigham And Women's Hospital, Inc. Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors
CA2343934A1 (en) 1998-09-25 2000-04-06 The Children's Medical Center Corporation Short peptides which selectively modulate the activity of protein kinases
US6211361B1 (en) * 1999-07-20 2001-04-03 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon, State Univeristy Method for making debromohymenialdisine and analogs thereof
DE69912808T2 (de) * 1999-12-08 2004-09-30 Centre National De La Recherche Scientifique (C.N.R.S.) Verwendung von Hymenialdisin und dessen Derivaten zur Herstellung therapeutischer Mittel
EP1250137B1 (de) * 2000-01-24 2007-08-15 Genzyme Corporation Inhibitoren des jak/stat-weges und deren verwendung zur behandlung von allgemeiner primärer osteoarthritis
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
WO2004058762A1 (en) * 2002-12-20 2004-07-15 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
MXPA05011777A (es) * 2003-05-08 2006-01-26 Wyeth Corp Proteina cinasa c zeta como un farmaco blanco para la artritis y otras enfermadades inflamatorias.
WO2004103958A2 (en) * 2003-05-19 2004-12-02 Michigan State University Preparation of hymenialdisine derivatives and use thereof
EP3616725A1 (de) 2018-08-27 2020-03-04 SmartDyeLivery GmbH Pkc-inhibitoren zur behandlung von septischer cholestase mit polymethinfarbstofftargeting
EP3616724A1 (de) 2018-08-27 2020-03-04 SmartDyeLivery GmbH Pkc-inhibitoren zur behandlung von septischer cholestase mit ctm-targeting

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729996A (en) * 1986-05-29 1988-03-08 Harbor Branch Oceanographic Institution, Inc. Antitumor compositions and their methods of use

Also Published As

Publication number Publication date
US5565448A (en) 1996-10-15
EP0630245A4 (de) 1994-11-02
AU3731293A (en) 1993-09-13
DE69323185D1 (de) 1999-03-04
EP0630245A1 (de) 1994-12-28
WO1993016703A1 (en) 1993-09-02
JPH07506094A (ja) 1995-07-06
JP3375131B2 (ja) 2003-02-10
EP0630245B1 (de) 1999-01-20

Similar Documents

Publication Publication Date Title
DE69435267D1 (de) Proteinkinase C Inhibitoren
DK0776895T3 (da) Proteinkinase C inhibitor
NO974453D0 (no) Proteinkinase C-hemmere
DE69323185D1 (de) Proteinkinase c-inhibitor
NO942064D0 (no) yminhibitorer
DK91192D0 (da) Protein
DE69627179T2 (de) Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren
DE69217375T2 (de) Bestimmungsverfahren
NO941142D0 (no) Tumor-nekrosefaktormuteiner
FI934588A0 (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
ZA949611B (en) Protein kinase C inhibitors
FI931645A (fi) Vaexel till hissmaskin
FI245U1 (fi) Takterrass till husbil
ITMI930345A0 (it) N-acil-peptidi inibitori delle protein-chinasi
DK120792D0 (da) Protein
SI0657458T1 (en) Protein kinase C inhibitors
IL122092A0 (en) Protein kinase C inhibitors
KR940026042U (ko) 서가
FI334U1 (fi) Doseringsanordning foer vaetskefoder till en boskapsmatningsmaskin
FI80U1 (fi) Gavelbegraensare till sladdblod
FI91U1 (fi) Stoedkaelke till spridare
FI386U1 (fi) Till laeget instaellbar fordonssits
FI297U1 (fi) Till arbetsmaskin kopplingsbar klyvnings- och buntningsanordning foer rundvirke
SE9203480L (sv) Kassalåda
FI924760A0 (fi) Staol till rundtimmersvarv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition